David Frazier, MD
Clinical Cardiac Electrophysiology · Greenville, NCNPI 1114076395
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (36.4%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Biotronik Inc. accounts for 79.8% of it on its own, with 34 other manufacturers making up the rest. Reporting peaked in 2024 at $15,959 and has fallen 80.9% since, to $3,046 in 2025.
Across 734 payments — averaging $78.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotronik Inc.$46K
- Medtronic$3K
- Abbott$3K
- Boston Scientific$1K
- Johnson & Johnson$880
- Sanofi-aventis U.S. LLC$797
- plus $3K from 29 others
Across 1,000 payments — averaging $112.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biotronik Inc.$112K
What the payments were for
- Consulting fees$17,20030%
- Speaking & faculty fees$1,0502%
- Travel & lodging$21,06736%
- Food & beverage$18,42632%
- Education$1410%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotronik Inc. | 207 | $46,174 |
| Medtronic(2 entities) | 63 | $3,010 |
| Abbott | 60 | $2,724 |
| Boston Scientific | 86 | $1,336 |
| Johnson & Johnson | 59 | $880 |
| Sanofi-aventis U.S. LLC | 42 | $797 |
| E.r. Squibb & Sons, L.L.C. | 82 | $722 |
| Atricure, Inc. | 7 | $302 |
| Pfizer | 31 | $290 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 23 | $237 |
| Boehringer Ingelheim | 10 | $156 |
| Globus Medical | 1 | $147 |
| Lundbeck LLC | 8 | $133 |
| Novartis | 8 | $129 |
| Infobionic, Inc | 3 | $120 |
| Amarin Pharma, Inc. | 7 | $101 |
| Cardiva Medical, Inc. | 4 | $84 |
| Hikma Pharmaceuticals USA | 5 | $77 |
| Kowa Pharmaceuticals America, Inc. | 5 | $67 |
| Lexicon Pharmaceuticals, Inc. | 3 | $66 |
| Elutia, Inc. | 4 | $58 |
| Altathera Pharmaceuticals LLC | 2 | $36 |
| AstraZeneca | 2 | $30 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Biosense Webster, Inc. | 1 | $23 |
| Scpharmaceuticals Inc. | 1 | $22 |
| Kestra Medical Technology Services, Inc. | 1 | $19 |
| Philips North America LLC | 1 | $19 |
| Medicomp Inc | 1 | $18 |
| Baxter Healthcare | 1 | $16 |
| Irhythm Technologies, Inc. | 1 | $15 |
| G Medical Diagnostic Services, Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Bardy Diagnostics, Inc. | 1 | $12 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Solia$9,813
- Selectra$9,727
- Edora 8 DR-T$8,728
- BioMonitor$3,355
- Acticor 7 VR-T DX$2,807
- Rivacor 7 DR-T$2,051
- AMVIA EDGE$1,772
- Arctic Front$1,410
- EnSite Precision Cardiac Mapping System$1,306
- PAMIRA$380
- Acticor$380
- Edora$380
- Rivacor$380
- Sentus$272
- Plexa$272
- XLIF$147
- AFFERA MAPPING SYSTEM$135
- Farapulse$129
- XARELTO$128
- CAMZYOS$117
How this compares
$57,884 in reported general payments places this provider in the 80th percentile of 98 clinical cardiac electrophysiology providers in North Carolina.
See all clinical cardiac electrophysiology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 918 | $850,826 |
| MultaqDronedarone Hcl | 304 | $357,240 |
| XareltoRivaroxaban | 232 | $208,859 |
| EntrestoSacubitril/Valsartan | 34 | $44,801 |
| Droxidopa | 47 | $38,697 |
| Ranolazine ErRanolazine | 457 | $30,756 |
| Dofetilide | 147 | $27,088 |
| Flecainide Acetate | 388 | $14,966 |
| Nebivolol Hcl | 316 | $14,083 |
| Propafenone Hcl | 213 | $8,479 |
| Quinidine Sulfate | 13 | $8,036 |
| SotalolSotalol Hcl | 408 | $7,498 |
| Amiodarone Hcl | 372 | $4,980 |
| Bisoprolol Fumarate | 193 | $4,278 |
| Midodrine Hcl | 38 | $3,107 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $290 | $850,826918 claims |
| Sanofi-aventis U.S. LLCMultaq | $797 | $357,240304 claims |
| Johnson & JohnsonXarelto | $880 | $208,859232 claims |
| NovartisEntresto | $129 | $44,80134 claims |
| Kowa Pharmaceuticals America, Inc.Bystolic | $67 | $2,21412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 98 clinical cardiac electrophysiology providers in North Carolina.
Other clinical cardiac electrophysiology in Greenville
- Gregory HarrisGreenville$164K
- John CatanzaroGreenville$159K
- Ghanshyam Palamaner Subash ShanthaGreenville$95K
- Dinesh VorugantiGreenville$32K
- Fabrizio Rodrigues AssisGreenville$15K
- Michael ManogueAsheville$230K
- Daniel FriedmanDurham$196K
- James AllredGreensboro$184K
- John RhynerAsheville$168K
- Kevin ManochaRaleigh$146K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.